Miaoqing Zhuang

Miaoqing Zhuang

Auto-generated profile, based on publicly available information

Miaoqing Zhuang

Department of Nursing, College of Nursing and Rehabilitation, Xi'an Jiaotong University City College, Xi 'an, China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 May 2025 in Journal of Medical Internet Research
Verified
Journal Article
Open access
MZMiaoqing Zhuang
Miaoqing Zhuang
IHIntan Idiana Hassan
Intan Idiana Hassan
WAWan Muhamad Amir W Ahmad
Wan Muhamad Amir W Ahmad
AKArifah Abdul kadir
Arifah Abdul kadir
XLXiaodong Liu
Xiaodong Liu
SSShuting Song
Shuting Song
Background: Chronic obstructive pulmonary disease (COPD), marked by dyspnea, cough, and sputum production, significantly impairs patients’ quality of life and functionality. Effective management strategies, particularly those empowering patients to manage their condition, are essential to reduce this burden and health care use. Digital health interventions—such as mobile apps for symptom tracking, wearable sensors for vital sign monitoring, and web-based pulmonary rehabilitation programs—can enhance self-efficacy and promote greater patient engagement. By improving self-management skills, these interventions also help alleviate pressure on health care systems. Objective: This systematic review and meta-analysis assesses the clinical effectiveness of smartphone apps, wearable monitors, and web-delivered platforms in four COPD management areas: (1) quality of life (measured by the COPD Assessment Test [CAT] and St George’s Respiratory Questionnaire), (2) self-efficacy (assessed by the General Self-Efficacy Scale), (3) functional capacity (evaluated via the 6-minute walk test and Modified Medical Research Council Dyspnea Scale), and (4) health care use (indicated by hospital and emergency department visits). Methods: A systematic review was conducted using predefined search terms in PubMed, Embase, Cochrane, and Web of Science up to January 26, 2025, to identify randomized trials on digital health interventions for COPD. Two reviewers independently screened studies and extracted data. Outcomes included quality of life, self-efficacy, functional status, and health care use. Results: This review included 17 studies with 2027 participants from 11 countries. Eleven trials involved health care professionals in digital platform use, and 12 reported adherence strategies. Digital tools for COPD primarily focused on telerehabilitation (eg, video-guided exercises) and self-management systems (eg, artificial intelligence–driven exacerbation alerts). The study participants were predominantly older adults. Meta-analysis results indicated that digital health interventions significantly improved quality of life at 3 months on the CAT (mean difference [MD] −1.65, 95% CI –3.17 to –0.14; P=.03); at 6 months on the CAT (MD −2.43, 95% CI −3.93 to −0.94; P=.001) and St George’s Respiratory Questionnaire (MD 3.25, 95% CI 0.69-5.81; P=.01); at 12 months on the CAT (MD −2.53, 95% CI −3.91 to −1.16; P<.001), EQ-5D (MD 0.04, 95% CI 0.01-0.07; P=.02), and EQ-5D visual analogue scale (MD 5.88, 95% CI 0.38-11.37; P=.04); the General Self-Efficacy Scale at 3 months (MD 1.65, 95% CI 0.62-2.69; P=.002) and 6 months (MD 1.94, 95% CI 0.83-3.05; P<.001); and the Modified Medical Research Council Dyspnea Scale at more than 3 months (MD −0.23, 95% CI −0.36 to −0.11; P=.003). However, no significant differences were observed in the 6-minute walk test, emergency department admissions, hospital admissions, emergency department admissions for COPD, or hospital admissions for COPD. Conclusions: Our findings suggest that digital health interventions may benefit COPD patients, but their clinical effectiveness remains uncertain. Further robust studies are needed, particularly those involving larger numbers of older adults with COPD. Trial Registration: PROSPERO CRD420251032053; https://www.crd.york.ac.uk/PROSPERO/view/CRD420251032053

30 October 2026 in JMIR Preprints
Verified
Preprint
Open access
MZMiaoqing Zhuang
Miaoqing Zhuang
IHIntan Idiana Hassan
Intan Idiana Hassan
XLXiaodong Liu
Xiaodong Liu
WAWan Muhamad Amir W Ahmad
Wan Muhamad Amir W Ahmad
AKArifah Abdul kadir
Arifah Abdul kadir
BACKGROUND Older adults with chronic obstructive pulmonary disease (COPD) face significant self-management challenges. Digital interventions tailored to their usability needs and grounded in behavioral theory remain scarce in China. This study evaluates a web-based health intervention module embedded within the SLH-COPD platform, specifically adapted for this population. OBJECTIVE To evaluate the usability and effectiveness of the SLH-COPD platform on self-management, health literacy, social support, and acute exacerbations among older adults with COPD. METHODS This single-blind randomized controlled trial was registered with the Chinese Clinical Trial Registry (ChiCTR-25-333181). Participants were randomly assigned (1:1) to an intervention group receiving the web-based health intervention module via the SLH-COPD platform or a control group receiving standard health education. The intervention module provided structured COPD self-management education, symptom and exacerbation monitoring, medication and breathing exercise guidance, and peer or nurse-supported feedback] over 3 months. Allocation was generated by computer-generated simple randomization, concealed using sequentially opened sealed opaque envelopes, and outcome assessors were blinded. Primary outcomes included self-management and acute exacerbations at baseline, 1 month, and 3 months. Secondary outcomes included COPD knowledge, social support, and system usability (intervention group only). RESULTS A total of 115 participants were enrolled. Compared with controls, the intervention group showed significant improvements in self-management, social support, and health literacy, alongside reduced acute exacerbations at 3 months (all p < 0.001). The platform achieved a mean SUS score of 72.76 (SD = 9.97), indicating high usability. CONCLUSIONS The theory-based, age-friendly SLH-COPD module demonstrates high usability and effectiveness in improving self-management and reducing exacerbations among older Chinese adults with COPD, effectively bridging the digital divide. CLINICALTRIAL This single-blind randomized controlled trial was registered with the Chinese Clinical Trial Registry (ChiCTR-25-333181)

21 April 2025 in JMIR Preprints
Verified
Preprint
Open access
MZMiaoqing Zhuang
Miaoqing Zhuang
IHIntan Idiana Hassan
Intan Idiana Hassan
WAWan Muhamad Amir W Ahmad
Wan Muhamad Amir W Ahmad
AKArifah Abdul kadir
Arifah Abdul kadir
XLXiaodong Liu
Xiaodong Liu
SSShuting Song
Shuting Song
BACKGROUND Chronic obstructive pulmonary disease (COPD), marked by dyspnea, cough, and sputum production, significantly impairs patients’ quality of life and functionality. Effective management strategies, particularly those empowering patients to manage their condition, are essential to reduce this burden and health care use. Digital health interventions—such as mobile apps for symptom tracking, wearable sensors for vital sign monitoring, and web-based pulmonary rehabilitation programs—can enhance self-efficacy and promote greater patient engagement. By improving self-management skills, these interventions also help alleviate pressure on health care systems. OBJECTIVE This systematic review and meta-analysis assesses the clinical effectiveness of smartphone apps, wearable monitors, and web-delivered platforms in four COPD management areas: (1) quality of life (measured by the COPD Assessment Test [CAT] and St George’s Respiratory Questionnaire), (2) self-efficacy (assessed by the General Self-Efficacy Scale), (3) functional capacity (evaluated via the 6-minute walk test and Modified Medical Research Council Dyspnea Scale), and (4) health care use (indicated by hospital and emergency department visits). METHODS A systematic review was conducted using predefined search terms in PubMed, Embase, Cochrane, and Web of Science up to January 26, 2025, to identify randomized trials on digital health interventions for COPD. Two reviewers independently screened studies and extracted data. Outcomes included quality of life, self-efficacy, functional status, and health care use. RESULTS This review included 17 studies with 2027 participants from 11 countries. Eleven trials involved health care professionals in digital platform use, and 12 reported adherence strategies. Digital tools for COPD primarily focused on telerehabilitation (eg, video-guided exercises) and self-management systems (eg, artificial intelligence–driven exacerbation alerts). The study participants were predominantly older adults. Meta-analysis results indicated that digital health interventions significantly improved quality of life at 3 months on the CAT (mean difference [MD] −1.65, 95% CI –3.17 to –0.14; P=.03); at 6 months on the CAT (MD −2.43, 95% CI −3.93 to −0.94; P=.001) and St George’s Respiratory Questionnaire (MD 3.25, 95% CI 0.69-5.81; P=.01); at 12 months on the CAT (MD −2.53, 95% CI −3.91 to −1.16; P<.001), EQ-5D (MD 0.04, 95% CI 0.01-0.07; P=.02), and EQ-5D visual analogue scale (MD 5.88, 95% CI 0.38-11.37; P=.04); the General Self-Efficacy Scale at 3 months (MD 1.65, 95% CI 0.62-2.69; P=.002) and 6 months (MD 1.94, 95% CI 0.83-3.05; P<.001); and the Modified Medical Research Council Dyspnea Scale at more than 3 months (MD −0.23, 95% CI −0.36 to −0.11; P=.003). However, no significant differences were observed in the 6-minute walk test, emergency department admissions, hospital admissions, emergency department admissions for COPD, or hospital admissions for COPD. CONCLUSIONS Our findings suggest that digital health interventions may benefit COPD patients, but their clinical effectiveness remains uncertain. Further robust studies are needed, particularly those involving larger numbers of older adults with COPD. CLINICALTRIAL PROSPERO CRD420251032053; https://www.crd.york.ac.uk/PROSPERO/view/CRD420251032053

26 July 2026 in JMIR Preprints
Verified
Preprint
Open access
MZMiaoqing Zhuang
Miaoqing Zhuang
IHIntan Idiana Hassan
Intan Idiana Hassan
XLXiaodong Liu
Xiaodong Liu
WAWan Muhamad Amir W Ahmad
Wan Muhamad Amir W Ahmad
AKArifah Abdul kadir
Arifah Abdul kadir
BACKGROUND Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are the leading cause of hospitalization and mortality, imposing a disproportionate burden on elderly patients. While web-based digital interventions offer promising strategies for remote management, their specific efficacy in reducing exacerbation frequency and healthcare utilization in the geriatric population remains uncertain. OBJECTIVE Objective To evaluate the effectiveness of web-based digital interventions on acute exacerbations, hospitalizations, and safety outcomes in elderly patients with COPD. METHODS Methods We systematically searched PubMed, EMBASE, Cochrane Library, Scopus, and Web of Science up to February 2nd, 2026 for randomized controlled trials (RCTs) evaluating web-based digital interventions in patients aged ≥60 years with COPD. Primary outcomes were the frequency of acute exacerbations and hospitalization rates. Data were pooled using random-effects models. RESULTS Results Seventeen RCTs involving 2,595 elderly participants were included. Meta-analysis revealed a time-dependent effect on acute exacerbation frequency: interventions significantly reduced exacerbations at 6 months (MD = 0.63, 95% CI [0.43, 0.83]; P < 0.00001) but not at 12 months (MD = 0.16, 95% CI [-0.09, 0.41]; P = 0.20), with no significant difference in the overall frequency (MD = 0.21, P = 0.26). Crucially, despite the transient effect on frequency, interventions significantly reduced the risk of any hospitalization (OR = 0.71, 95% CI [0.51, 0.99]; P = 0.05) and readmissions (OR = 0.76, 95% CI [0.61, 0.96]; P = 0.02), with benefits sustained at 12 months for readmissions. While all-cause hospitalization frequency at 6 months decreased significantly (MD = -0.34, P = 0.004), no significant differences were found in COPD-specific hospitalization rates, length of stay, emergency visits, or mortality (OR = 0.89, P = 0.55). CONCLUSIONS Conclusion Web-based digital interventions for elderly COPD patients demonstrate a dissociation between total exacerbation frequency and hospitalization rates. While the reduction in overall exacerbation frequency may attenuate over time, these interventions significantly reduce the risk of hospitalization and readmission, suggesting they are particularly effective in preventing severe exacerbations. Future implementation should prioritize hybrid models combining web-based tools with proactive human support to sustain long-term benefits in this vulnerable population. CLINICALTRIAL The protocol for this study was registered in PROSPERO, the international prospective register for systematic reviews (CRD420261298413). INTERNATIONAL REGISTERED REPORT RR2-10.2196/76323

13 July 2026 in JMIR Preprints
Verified
Preprint
Open access
MZMiaoqing Zhuang
Miaoqing Zhuang
IHIntan Idiana Hassan
Intan Idiana Hassan
XLXiaodong Liu
Xiaodong Liu
WAWan Muhamad Amir W Ahmad
Wan Muhamad Amir W Ahmad
AKArifah Abdul kadir
Arifah Abdul kadir
BACKGROUND Chronic obstructive pulmonary disease (COPD) imposes a substantial burden on older adults, yet existing digital self-management interventions often fail to address age-specific usability barriers and lack integration of established behavioral and technology acceptance theories. While web-based platforms hold promise for supporting COPD management, few have been systematically developed with direct input from older patients and validated through rigorous mixed-methods usability evaluation in the Chinese healthcare context. OBJECTIVE To describe the theory-guided development process and evaluate the usability of a web-based self-management module embedded within the SLH-COPD platform, specifically designed for older adults with COPD in China. METHODS This study employed a sequential exploratory mixed-methods design comprising three phases. In Phase 1 (Module Development), the COPD digital health intervention module was developed and finalized based on findings from prior research, a systematic literature review, and two rounds of Delphi expert consultation. Phase 2 involved the technical configuration and integration of the module into the SLH-COPD platform. In Phase 3 (Validation), alpha and beta testing were conducted with older adults with COPD; usability was assessed using the UMUX alongside objective behavioral data to inform iterative refinement of the module. RESULTS Using a mixed-methods design, this study successfully constructed and optimized a web-based self-management module for older adults with COPD, embedded within the SLH-COPD platform. A cross-sectional survey (n=199) identified five core domains of user needs, including symptom monitoring, medication management, and rehabilitation exercise. Following two rounds of Delphi Method (n=17, authority coefficient Cr=0.88), expert consensus was satisfactory, with Kendall’ s W values of 0.230, 0.321, and 0.285 for first-, second-, and third-level indicators, respectively (P<0.05). The final intervention framework comprised 5 first-level, 14 second-level, and 34 third-level indicators, demonstrating excellent content validity (S-CVI/Ave=0.988) and item-level CVIs (I-CVI) ranging from 0.80-1.00. Consistency testing using the AHP yielded a random CR of 0.009 ( 85%. Qualitative feedback confirmed that senior-friendly designs and plain-language, localized content effectively improved the user experience among low-literacy older adults. CONCLUSIONS This study confirms that the theory-guided web-based self-management module for older COPD patients demonstrates adequate content validity and usability, with senior-friendly design effectively meeting user needs. It provides a replicable development and validation paradigm for digital chronic disease interventions in older adults. Future randomized controlled trials are needed to evaluate its clinical effectiveness and long-term adherence. CLINICALTRIAL Chinese Clinical Trial Registry (ChiCTR number):PID331832